| NCT03213626 |
Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma |
View |
| NCT02121626 |
The FOCCUS Study: ȯocusing on Cancers Chemotherapys' Untreated Symptoms" |
View |
| NCT05391126 |
GENOCARE: a Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care |
View |
| NCT06390826 |
Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V) |
View |
| NCT02754726 |
Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma |
View |
| NCT03316326 |
S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer |
View |
| NCT00899626 |
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples from Colorectal Cancer Patients |
View |
| NCT01094626 |
Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection |
View |
| NCT03058926 |
Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer |
View |
| NCT04483726 |
Distal Pancreatectomy, Minimally Invasive or Open, for Malignancy (DIPLOMA) |
View |
| NCT05610826 |
Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver |
View |
| NCT01703026 |
Contrast Enhanced EUS in the Evaluation of Pancreatic Cancer and Pancreatic Masses |
View |
| NCT02528526 |
Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm |
View |
| NCT05149326 |
KN046 in Subjects With Advanced Pancreatic Ductal Adenocarcinoma. |
View |
| NCT04716166 |
Incentive Spirometry and Upper Abdominal Laparoscopic Surgery |
View |
| NCT03817866 |
Chromogranin A as Blood Marker in Cancer Patients |
View |
| NCT02695966 |
EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer |
View |
| NCT00593866 |
Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer |
View |
| NCT05635266 |
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives |
View |
| NCT05009966 |
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor |
View |
| NCT03475966 |
Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program |
View |
| NCT00358566 |
GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer |
View |
| NCT00515866 |
Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer |
View |
| NCT05968326 |
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC |
View |
| NCT00003426 |
Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer |
View |
